首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1439476

耳鼻喉科設備-全球市場回顧、競爭格局、市場預測（2030年）

ENT Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

預計2023年全球耳鼻喉科市場規模將達168億美元，2030年將達250.2億美元，2024-2030年預測期間內複合年增長率為6.89%。市場的成長是由於由於受傷、病毒和細菌感染、癌症、過敏性鼻炎等慢性疾病以及老年人口的增加而導致的各種耳鼻喉問題的增加。聽力損失病例的增加也是耳鼻喉科設備市場的主要成長動力。微創耳鼻喉外科設備的各種技術發展也促進了該市場的成長。多年來整形外科的蓬勃發展也顯示對有效耳鼻喉設備的需求不斷增加。

耳鼻喉科設備市場動態

耳鼻喉科設備的成長是由於慢性病、損傷、感染和人口老化等多種因素造成的。

頭頸癌的盛行率不斷上升，需要徹底的診斷和腫瘤切除手術，這是市場成長的重要因素。根據美國國家癌症研究所 (2022) 的數據，頭頸癌病例占美國所有癌症病例的 4%。全球範圍內影響耳鼻喉健康的細菌和病毒感染的增加也導致對耳鼻喉診斷/手術設備的需求增加。例如，根據世界衛生組織（WHO）2022年公佈的數據，一個人從細菌性腦膜炎康復後，面臨聽力、語言和溝通能力喪失等長期影響的幾率為每人5人。此外，聽力損失隨著年齡的增長而下降，需要立即採取措施，例如助聽器或植入物，這就是為什麼進行手術的原因。這也導致市場成長。

耳鼻喉科設備市場成長的另一個主要因素是新技術的開發，以可負擔的成本進行有效的微創手術。例如，佐治亞理工學院的研究人員開發了一種超低成本、負擔得起的助聽器，以幫助數百萬患有與年齡相關的聽力損失的人。

久坐的生活方式是耳鼻喉科設備市場的另一個成長動力，因為它會導致生活方式疾病，包括阻塞性睡眠呼吸中止症和其他呼吸問題。根據美國睡眠醫學會的數據，大約 3,000 萬美國成年人患有阻塞性睡眠呼吸中止症 (OSA)。急性和慢性季節性過敏病例，包括過敏性鼻炎和特定過敏原引起的鼻竇炎，也對耳鼻喉科設備市場有正面影響。根據世界過敏組織（2020）的最新數據，目前全球約有4億人患有過敏性鼻炎，其中大多數人未經診斷和治療。

由於全球整容手術的增加，耳鼻喉科設備市場也呈現出正面的成長。人們開始追求外表美麗，微創、安全的手術也以實惠的價格成為可能，這進一步激發了整容手術行業的活力，耳鼻喉科設備市場也隨之大幅增長。

然而，發展中國家獲得負擔得起的耳鼻喉科產品的機會有限以及缺乏熟練的耳鼻喉科專家是耳鼻喉科設備市場增長的主要限制因素。

在 COVID-19 大流行期間，隨著重點轉向首先治療 COVID-19 患者，耳鼻喉科設備市場的成長略有下降。在大流行期間，醫院因封鎖而關閉了耳鼻喉科，以避免可能的感染傳播。然而，隨著COVID-19之後一切恢復正常，以及社會對耳鼻喉科健康和定期檢查意識的提高，耳鼻喉科手術正在增加。因此，預計2024-2030年預測期內市場將有效成長。

本報告提供了全球耳鼻喉科市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

推動耳鼻喉科市場的因素
- 耳鼻喉相關問題增加
- 老年人口增加
- 技術進步
- 整容手術增加
耳鼻喉科設備市場的抑制因素與挑戰
- 缺乏熟練的耳鼻喉科醫生
- 與耳鼻喉科設備相關的併發症
耳鼻喉科設備市場的機遇
- 提高產品安全性
- 價格實惠的耳鼻喉科產品

第5章波特五力分析耳鼻喉科設備市場

第6章 COVID-19 對耳鼻喉科設備市場的影響分析

第7章耳鼻喉科設備市場佈局

依裝置類型
- 耳鼻喉科診斷設備
- 耳鼻喉外科手術設備
- 助聽器
- 聽力植入物
- 鼻夾板
- 其他
透過治療
- 喉鏡檢查
- 功能性內視鏡鼻竇手術
- 扁桃體切除術、腺樣體切除術
使用性別
- 一次性
- 可重複使用
依年齡段
- 兒童
- 成人
按最終用戶
- 醫院
- 耳鼻喉科診所
按地區
- 北美
- 歐洲
- 亞太地區
- 其他領域

第 8 章耳鼻喉科設備市場：全球公司份額分析 - 3 至 5 家主要公司

第9章耳鼻喉科設備市場公司及產品概況

Medtronic
Starkey
Johnson & Johnson Services, Inc.
Smith and Nephew Plc.
Fude Technology Group Limited
Cochlear Limited
Olympus America
Stryker Corporation
Sonova Holding AG
Atos medical Ab
MED-EL Medical Electronics
Firefly Global
RION Co., Ltd.
GN Store Nord A/S
Welch Allyn®
Karl Storz Gmbh & co.
Demant A/S
B. Braun Melsungen AG
WS Audiology A/S
PENTAX Medical

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0291

ENT Devices Market By Device Type (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints, And Others) Procedure Type (Laryngoscopy, Functional Endoscopic Sinus Surgery, Tonsillectomy, Adenoidectomy, And Others) By Usability (Disposable And Reusable) By Age Group (Pediatric And Adults) By End-User (Hospitals, ENT Clinics, And Others) by geography is estimated to register a significant growth during the forecast period from 2024-2030 owing to surge in prevalence of ENT problems and technological advances in ENT devices.

The global ENT devices market was valued at USD 16.80 billion in 2023, growing at a CAGR of 6.89% during the forecast period from 2024 to 2030 to reach USD 25.02 billion by 2030. The positive growth in the ENT devices market is due to the rising prevalence of various Ear, Nose, and Throat problems as a result of injuries, viral and bacterial infections, chronic diseases like cancer, allergic rhinitis, and an increasing geriatric population. The growing cases of hearing loss or deafness are another major driver driving the market growth of ENT devices. The various technological developments for minimally invasive surgical ENT devices are another matter of fact for the growth of this market. The boom in plastic surgeries over many years also explains the growing need for effective ENT devices.

ENT Devices Market Dynamics:

The growth of ENT devices is owing to various factors including chronic diseases, injuries, infections, increasing age, and others.

The rising prevalence of head and neck cancer which requires thorough diagnosis and surgery for removal of the tumour is an important factor for market growth. According to National Cancer Institute 2022, out of total cancer cases in the US, the cases of head and neck cancer accounts for 4%. The increase in bacterial and viral infections worldwide affecting ear, nose, and throat health is also causing a rise in the demand for ENT diagnostic and surgical devices. For instance, according to the World Health Organization (WHO) data published in 2022, the probability of an individual facing long-term effects such as loss of hearing, speech, and communication after getting recovered from bacterial meningitis is 1 out of 5. Along with this the decrease or overall loss of hearing ability with increasing age requires immediate action in form of hearing aids and implants, for which surgeries are done eventually leading to the growth of the ENT devices market.

The other important factor for the ENT devices market growth is the new technological developments happening for effective but minimally invasive procedures at affordable costs. For instance, Georgia Tech researchers have developed affordable ultra-low-cost hearing aid to help millions of people suffering from age-related hearing loss.

The sedentary lifestyle is another driving factor for the ENT devices market growth as it leads to lifestyle-based diseases including obstructive sleep apnoea and other breathing problems. According to American Academy of Sleep Medicine, around 30 million American adults suffer from obstructive sleep apnoea (OSA). The acute and chronic cases of seasonal allergies including allergic rhinitis, and sinusitis owing to certain allergens also impact the ENT device market positively. As per the latest data available from World Allergy Organization 2020, currently around 400 million people are suffering from allergic rhinitis worldwide and most of them are neither diagnosed nor treated.

The ENT device market is also seeing positive growth due to the rise in cosmetic surgeries happening worldwide. People getting more inclined toward enhancing their physical appearances and the availability of minimally invasive and safe procedures at affordable rates are further driving the cosmetic surgery industry and thus leading to remarkable growth in the ENT devices market growth also.

However, the lack of skilled ENT specialists and limited access to affordable ENT products in developing nations are certain key factors hampering the ENT devices market growth.

During the period of the COVID-19 pandemic, the ENT device market growth has shown some decline due to shifted primary focus on first treating patients suffering from Coronavirus. The hospitals closed down the ENT department during the pandemic owing to lockdown and also to avoid any chance of spread of infection. However, as everything has been normalized post-COVID-19, and with the increase in public awareness of ENT health and regular check-ups, there is a growth in ENT surgeries. Thus, the market seems to grow effectively during the forecast period from 2024 to 2030.

ENT Devices Market Segment Analysis:

ENT Devices Market by Device type (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints, and Others) Procedure type (Laryngoscopy, Functional Endoscopic Sinus Surgery, Tonsillectomy, Adenoidectomy, and Others) Usability (Disposable and Reusable), Age Group (Paediatric and Adults), End-User (Hospitals, ENT Clinics, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Based on the device type segment, hearing implants are going to register significant growth in revenue in the ENT devices market during the forecast period (2024-2030). This can be ascribed to the rising prevalence of hearing loss owing to factors such as aging, inappropriate use of drugs and medications, infections like rubella, syphilis, and jaundice, among others. For instance, according to World Health Organization (WHO) 2022, the probability of suffering even a slight degree of hearing loss by 2050 will be 1 out of 4.

Also, the technological advancement in form of artificial intelligence, small device size, and minimum invasiveness in solving hearing impairment can prove to be an important factor for hearing implant market growth. For example, according to National Institute on Deafness and Other Communication Disorders (2023), approximately 736,900 registered device implantation have been performed in December 2019 worldwide. This gives an insight into the hearing implant market growth.

Therefore, considering the growing demand for this product type, numerous new products are also being launched in the market. For instance, in August 2022 Cochlear Limited, pioneers in implantable hearing solutions announced the launch of the world's smallest off-the-ear cochlear implant sound processor Nucleus® Kanso® 2 in Singapore which helps in improving hearing in people with hearing loss. Therefore, considering the prevalence of hearing loss and the growing need for hearing implants among end-users, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global ENT devices market during the forecast period.

North America is expected to dominate the overall ENT Devices Market:

The ENT device market is going to see prosperity in the North America region specifically owing to key factors including underlying diseases like cancer, allergic rhinitis, sinusitis, new technological advancements, high-tech medical facilities, government support, and awareness regarding ENT health among others.

The cases of allergic sinusitis are highly prevalent in the United States. Sinusitis is an illness of the nose and sinuses which is marked by symptoms like nasal blockage, inflammation, pain in the noses and sinuses, fever, nasal discharge, and others. According to the Centers for Disease Control and Prevention (CDC) 2022, around 28.9 million adults were diagnosed with sinusitis in the U.S in the year 2018. The large population affected by chronic sinusitis requires proper diagnosis and treatment in terms of surgery thereby driving the growth of the ENT devices market in the North America region.

Further, cases of hearing impairment are also on the rise owing to bacterial and viral infections, injuries, noise pollution, and a growing geriatric population. Hearing aids and cochlear implants are widely used for such problems in the country. According to the U.S. Food and Drug Administration (FDA) 2022, roughly around 118,100 and 65,000 cochlear implants have been implanted in adults and children respectively in the U.S. in the year 2019. This shows an enormous market growth opportunity for ENT devices in the U.S. region.

Thyroid cancer incidences are another key driver for growth in the ENT devices market in the region. For instance, according to the American Cancer Society 2022, the estimated number of new cases of thyroid cancer in the US for the year 2022 is 43,800 out of which 31,940 new cases in women and 11,860 in men. An adequate diagnosis and surgical treatments like minimally invasive, video-assisted thyroidectomy, endoscopic or robotic thyroidectomy are suggested by ENT specialists for thyroid surgery.

Head and neck cancer also drives the growth of the ENT devices market in the US. As per the National Cancer Institute 2022, estimated head and neck cancer cases diagnosed were more than 68,000 in the year 2023 in the United States.

Apart from general treatment options including surgery of the head and neck, and laryngectomy, sometimes plastic and reconstructive surgery may also require depending upon the severity and thus leading to an overall increase in the ENT devices market growth in the region.

ENT Devices Market Key Players:

Some of the key market players operating in the ENT Devices market include Medtronic, Starkey, Smith and Nephew Plc., Fude Technology Group Limited, Cochlear Limited, Olympus America, Stryker Corporation, Johnson & Johnson Services, Inc., Sonova Holding AG, Atos medical Ab, MED-EL Medical Electronics, Firefly Global, RION Co., Ltd., GN Store Nord A/S, Welch Allyn®, Karl Storz Gmbh & co., Demant A/S, B. Braun Melsungen AG, WS Audiology A/S, PENTAX Medical, among others.

Recent Developmental Activities in ENT Devices Market:

In January 2022, Cochlear Limited (ASX: COH) received U.S. Food and Drug Administration (FDA) approval for its Cochlear(TM) Nucleus® which offers an implant for unilateral hearing loss (UHL)/single-sided deafness (SSD).

In August 2022, 3NT Medical received U.S. Food and Drug Administration (FDA) approval for Peregrine Drivable ENT Scope which allows ENT specialists to visualize in-depth intra-sinus anatomy with minimal resection.

In November 2020, SafKan Health received FDA clearance for its OtoSet which is the first automated ear cleaning system.

Key Takeaways from the ENT Devices Market Report Study

Market size analysis for current ENT devices market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ENT devices market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
Key companies dominating the global ENT devices market.
Various opportunities are available for the other competitor in the ENT devices market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current ENT devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for ENT devices market growth in the coming future?

Target Audience who can be benefited from this ENT Devices Market Report Study

ENT devices products providers
Research organizations and consulting companies
ENT devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in ENT devices
Various end-users who want to know more about the ENT devices market and the latest technological developments in the ENT devices market.

Frequently Asked Questions for ENT Devices Market:

1. What are ENT devices?

ENT Devices are medical devices that are employed in the diagnosis, treatment, and management of ear, nose, and throat health.

2. What is the market for Global ENT devices?

The global ENT devices market was valued at USD 16.80 billion in 2023, growing at a CAGR of 6.89% during the forecast period from 2024 to 2030 to reach USD 25.02 billion by 2030.

3. What are the drivers for the global ENT devices Market?

The ENT device market is slated to witness prosperity owing to factors such as the growing prevalence of bacterial and viral infections, chronic diseases such as cancer, an increasingly sedentary lifestyle, a growing aging population base susceptible to the development of hearing loss, and the growing focus on improving the safety and usability of ENT devices for end-users are further expected to result in the appreciable revenue growth in the ENT devices market during the forecast period (2024-2030).

4. Who are the key players operating in the global ENT devices Market?

5. Which region has the highest share in the ENT devices market?

North America is expected to dominate the overall ENT devices market during the forecast period from 2024 to 2030. This can be ascribed to the presence of a large patient pool associated with hearing impairment, and chronic diseases like cancer, rhinitis, and sinusitis. The increase in obstructive sleep apnoea cases also increases the market for ENT devices in the region.

1.ENT Devices Market Report Introduction

2.ENT Devices Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. ENT Devices Market Key Factors Analysis

4.1. ENT Devices Market Drivers
- 4.1.1. Rising ENT-related Problems
- 4.1.2. Rising Geriatric Population
- 4.1.3. Technological advancements
- 4.1.4. Increase in Cosmetic Surgery
4.2. ENT Devices Market Restraints and Challenges
- 4.2.1. A dearth of skilled ENT specialists
- 4.2.2. Complications associated with ENT devices
4.3. ENT Devices Market Opportunities
- 4.3.1. Improving Product Safety
- 4.3.2. Affordable ENT products

5. ENT Devices Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on ENT Devices Market

7. ENT Devices Market Layout

7.1. By Device Type
- 7.1.1. Diagnostic ENT Devices
- 7.1.2. Surgical ENT Devices
- 7.1.3. Hearing Aids
- 7.1.4. Hearing Implants
- 7.1.5. Nasal Splints
- 7.1.6. Others
7.2. By Procedure
- 7.2.1. Laryngoscopy
- 7.2.2. Functional Endoscopic Sinus Surgery
- 7.2.3. Tonsillectomy and Adenoidectomy
- 7.2.4. Others
7.3. By Usability
- 7.3.1. Disposable
- 7.3.2. Reusable
7.4. By Age Group
- 7.4.1. Pediatric
- 7.4.2. Adults
7.5. By End-user
- 7.5.1. Hospitals
- 7.5.2. ENT Clinics
- 7.5.3. Others
7.6. By Geography
- 7.6.1. North America
  - 7.6.1.1. United States ENT Devices Market in USD million (2021-2030)
  - 7.6.1.2. Canada ENT Devices Market in USD million (2021-2030)
  - 7.6.1.3. Mexico ENT Devices Market in USD million (2021-2030)
- 7.6.2. Europe
  - 7.6.2.1. France ENT Devices Market in USD million (2021-2030)
  - 7.6.2.2. Germany ENT Devices Market in USD million (2021-2030)
  - 7.6.2.3. United Kingdom ENT Devices Market in USD million (2021-2030)
  - 7.6.2.4. Italy ENT Devices Market in USD million (2021-2030)
  - 7.6.2.5. Spain ENT Devices Market in USD million (2021-2030)
  - 7.6.2.6. Russia ENT Devices Market in USD million (2021-2030)
  - 7.6.2.7. Rest of Europe ENT Devices Market in USD million (2021-2030)
- 7.6.3. Asia-Pacific
  - 7.6.3.1. China ENT Devices Market in USD million (2021-2030)
  - 7.6.3.2. Japan ENT Devices Market in USD million (2021-2030)
  - 7.6.3.3. India ENT Devices Market in USD million (2021-2030)
  - 7.6.3.4. Australia ENT Devices Market in USD million (2021-2030)
  - 7.6.3.5. South Korea ENT Devices Market in USD million (2021-2030)
  - 7.6.3.6. Rest of Asia Pacific ENT Devices Market in USD million (2021-2030)
- 7.6.4. Rest of the World (RoW)
  - 7.6.4.1. Middle East ENT Devices Market in USD million (2021-2030)
  - 7.6.4.2. Africa ENT Devices Market in USD million (2021-2030)
  - 7.6.4.3. South America ENT Devices Market in USD million (2021-2030)

8. ENT Devices Market Global Company Share Analysis - Key 3-5 Companies

9. ENT Services Market Company and Product Profiles

9.1. Medtronic
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. Starkey
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. Johnson & Johnson Services, Inc.
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. Smith and Nephew Plc.
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. Fude Technology Group Limited
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. Cochlear Limited
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. Olympus America
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.6. Product Listing
- 9.7.5. Entropy
9.8. Stryker Corporation
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Sonova Holding AG
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. Atos medical Ab
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. MED-EL Medical Electronics
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. Firefly Global
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. RION Co., Ltd.
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. GN Store Nord A/S
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. Welch Allyn®
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Karl Storz Gmbh & co.
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. Demant A/S
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.6. Product Listing
- 9.17.5. Entropy
9.18. B. Braun Melsungen AG
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. WS Audiology A/S
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. PENTAX Medical
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy